MIR3680-2

Across TCGA pan-cancer cohorts, MIR3680-2 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated MIR3680-2 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR3680-2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3680-2 expression acts as an unfavorable survival marker, although some lineages such as BRCA and SKCM show a favorable association.

ACC, LIHC, and UVM are the cancer types where MIR3680-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.494	0.834	.001	63	view →
LIHC	DFS	Tertile	All	0.253	0.560	<.001	63	view →
UVM	DFS	Tertile	III,IV	0.120	0.747	.001	57	view →
THYM	OS	Tertile	All	0.482	0.943	<.001	39	view →
KIRP	DFS	Tertile	IV	0.088	0.502	<.001	36	view →
BRCA	DFS	Tertile	III,IV	0.770	0.426	.007	30	view →
SKCM	DFS	Tertile	III,IV	0.757	0.546	.014	21	view →
COAD	OS	Tertile	IV	0.188	0.699	.013	18	view →
CESC	DFS	Tertile	II,III,IV	0.625	0.816	.011	18	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →
SARC	OS	Tertile	All	0.427	0.834	.005	18	view →
UCEC	DFS	Tertile	All	0.821	0.901	.014	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

MIR3680-2–ACC (OS)

Open the ACC breakdown →